Metastasis of cancer from Merkel cells to the thyroid gland

Authors

  • Piotr Przyczyna Clinical Provincial Hospital No. 2 St. Jadwiga Krolowej in Rzeszow, Rzeszow, Poland; Department of Morphological Sciences, Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszow, Poland https://orcid.org/0000-0002-3142-6851
  • Elżbieta Trojnar Clinical Provincial Hospital No. 2 St. Jadwiga Krolowej in Rzeszow, Rzeszow, Poland
  • Dorota Bartusik-Aebisher Department of Biochemistry and General Chemistry, Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszow, Poland https://orcid.org/0000-0002-5557-5464
  • David Aebisher Department of Photomedicine and Physical Chemistry, Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszow, Poland https://orcid.org/0000-0002-2661-6570

DOI:

https://doi.org/10.15584/ejcem.2021.1.12

Keywords:

Merkel cells, metastasis of cancer, thyroid gland

Abstract

Introduction. Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine skin cancer.

Aim. Herein described is a case of hypertensive patient, after removal of Merkel cancer of the left gluteus skin (2011), after pulmonary embolism (2013), with degenerative changes of the spine and uterine myoma, chronically treated with Warfarin, because of suspected thyroid cancer.

Description of the case. A 70-year-old woman case after removing Merkel cancer of the left buttock skin (2011), after pulmonary embolism (2013), with degenerative changes of the spine and uterine fibroids treated chronically with Warfarin because of suspected thyroid cancer is described.

Conclusion. Increasing evidence of Merkel cell carcinoma with immunodeficiency and neoplasia, and the management and outcome of these patients requires study.

Downloads

Download data is not yet available.

References

Swann MH, Yoon J. Merkel cell carcinoma: clinicopathological aspects of an unusual neoplasm. Semin Oncol. 2007;34(1):51-56.

Heath M, Jaimes N, Lemos B, et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol. 2008;58(3):375-381.

Liapakis IE, Korkolis DP, Koutsoumbi A, Kokkalis G, Gherardini G, Vassilopoulos PP. Merkel cell carcinoma: clinicopathological aspects of an unusual neoplasm. J BUON. 2007;12(2):173-179.

Lemos B, Nghiem P. Merkel cell carcinoma: more deaths but still no pathway to blame. J Invest Dermatol. 2007;127(9):2100-2103.

Albores-Saavedra J, Batich K, Chable-Montero F, Sagy N, Schwartz AM, Henson DE. Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study. J Cutan Pathol. 2010;37(1):20-27.

Girschik J, Thorn K, Beer TW, Heenan PJ, Fritschi L. Merkel cell carcinoma in Western Australia: a population-based study of incidence and survival. Br J Dermatol. 2011;165(5):1051-1057.

Reichgelt BA, Visser O. Epidemiology and survival of Merkel cell carcinoma in the Netherlands: a population-based study of 808 cases in 1993-2007. Eur J Cancer. 2011;47(4):579-585.

Asgari MM, Sokil MM, Warton EM, Iyer, J, Paulson KG, Nghiem P. Effect of Host, Tumor, Diagnostic, and Treatment Variables on Outcomes in a Large Cohort With Merkel Cell Carcinoma. JAMA Dermatology. 2014;150(7):716.

Tarantola TI, Vallow LA, Halyard MY, et al. Unknown primary Merkel cell carcinoma: 23 new cases and a review. J Am Acad Dermatol. 2013;68(3):433-440.

Foote M, Veness M, Zarate D, Poulsen M. Merkel cell carcinoma: the prognostic implications of an occult primary in stage IIIB (nodal) disease. J Am Acad Dermatol. 2012;67(3):395-399.

Vaiciunaite D, Beddell G, Ivanov N. Merkel cell carcinoma: an aggressive cutaneous carcinoma with rare metastasis to the thyroid gland. BMJ Case Rep. 2019;12(4):e228273.

Downloads

Published

2021-03-30

How to Cite

Przyczyna, P., Trojnar, E., Bartusik-Aebisher, D., & Aebisher, D. (2021). Metastasis of cancer from Merkel cells to the thyroid gland. European Journal of Clinical and Experimental Medicine, 19(1), 86–88. https://doi.org/10.15584/ejcem.2021.1.12

Issue

Vol. 19 No. 1 (2021)

Section

CASUISTIC PAPERS

License

Copyright (c) 2021 European Journal of Clinical and Experimental Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.

All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.

Most read articles by the same author(s)

1 2 3 4 5 > >>